SCHEMBL18399564

SCHEMBL18399564

O=C(Nc1cnn2cccc2c1-c1ccccccccc1)C1CCCCCCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.48
HDAC1 Q13547 2/20 0.48
HDAC2 Q92769 2/20 0.48
ALDH1A1 P00352 3/20 0.47
ADORA1 P30542 5/20 0.46
HPGD P15428 2/20 0.46
CETP P11597 1/20 0.45
ADORA2A P29274 4/20 0.45
ADORA3 P0DMS8 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
TSHR P16473 2/20 0.44
USP2 O75604 1/20 0.44
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24832264 1.00 HDAC3 (0.48) HDAC3HDAC1HDAC2ALDH1A1ADORA1
SCHEMBL18399568 0.81 CETP (0.47) HDAC3HDAC1HDAC2ALDH1A1HPGD
SCHEMBL19059718 0.81 CETP (0.47) HDAC3HDAC1HDAC2ALDH1A1HPGD
SCHEMBL22853733 0.81 CETP (0.47) HDAC3HDAC1HDAC2ALDH1A1HPGD
SCHEMBL20368586 0.81 CETP (0.47) HDAC3HDAC1HDAC2ALDH1A1HPGD
SCHEMBL21781621 0.81 CETP (0.47) HDAC3HDAC1HDAC2ALDH1A1HPGD
SCHEMBL21158395 0.81 CETP (0.47) HDAC3HDAC1HDAC2ALDH1A1HPGD
SCHEMBL5849175 0.79 EPHB3 (0.60) ALDH1A1HPGDNPC1RAB9AKDM4E
SCHEMBL22018172 0.78 IDO1 (0.52) HDAC3HDAC1HDAC2ALDH1A1HPGD
SCHEMBL20368668 0.73 HDAC3 (0.51) HDAC3HDAC1HDAC2ALDH1A1ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9550765-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors INCYTE HOLDINGS CORPORATION (US) 2017-01-24 US disclosed